Gęca, K.; Litwiński, J.; Ostrowski, T.; Świetlicka, I.; Polkowski, W.P.; Skórzewska, M.
Exploring the Survival Determinants in Recurrent Ovarian Cancer: The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Cancers 2024, 16, 2150.
https://doi.org/10.3390/cancers16112150
AMA Style
Gęca K, Litwiński J, Ostrowski T, Świetlicka I, Polkowski WP, Skórzewska M.
Exploring the Survival Determinants in Recurrent Ovarian Cancer: The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Cancers. 2024; 16(11):2150.
https://doi.org/10.3390/cancers16112150
Chicago/Turabian Style
Gęca, Katarzyna, Jakub Litwiński, Tomasz Ostrowski, Izabela Świetlicka, Wojciech P. Polkowski, and Magdalena Skórzewska.
2024. "Exploring the Survival Determinants in Recurrent Ovarian Cancer: The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy" Cancers 16, no. 11: 2150.
https://doi.org/10.3390/cancers16112150
APA Style
Gęca, K., Litwiński, J., Ostrowski, T., Świetlicka, I., Polkowski, W. P., & Skórzewska, M.
(2024). Exploring the Survival Determinants in Recurrent Ovarian Cancer: The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Cancers, 16(11), 2150.
https://doi.org/10.3390/cancers16112150